Description: Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 3MIU include Slurred speech, upset stomach, gastrointestinal disturbance, generalized itching, red spots or bumps, increased blood urea nitrogen, increased creatinine level in blood, decreased creatinine clearance, respiratory distress, apnea (absence of breathing), renal toxicity, decreased urinary volume, dizziness, paresthesia (tingling or pricking sensation), vertigo, rash, and fever. Taj Pharma, based in Vapi, Gujarat, is a top-tier manufacturer, exporter, and supplier of Colistimethate Sodium for Injection IP 3MIU in India. This essential antibiotic is widely used in hospitals to treat life-threatening bacterial infections, especially those caused by multidrug-resistant Gram-negative bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii. Taj Pharma’s formulation meets WHO-GMP and international quality standards, ensuring safety, efficacy, and global regulatory compliance. Colistimethate Sodium for Injection IP 3MIU is administered under medical supervision, typically in ICU settings, and dosage is tailored based on infection severity and renal function. Taj Pharma’s product is known for its reliability, purity, and consistent therapeutic results, making it highly sought-after across India, Africa, the Middle East, and LATAM regions. The injection may cause mild side effects such as dizziness, rash, or kidney-related issues, especially in patients with pre-existing renal conditions. Taj Pharma also provides PCD Pharma franchise opportunities with monopoly rights, promotional support, and a strong distribution network across India. With a commitment to affordability, quality, and patient safety, Taj Pharma is recognized as one of the leading suppliers of Colistimethate Sodium for Injection IP 3MIU worldwide. Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 278 KB
